biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by amillionorbuston Apr 06, 2020 1:08pm

168 Views

Post# 30883491

RE:RE:RE:Value Proposition

Wow chrispi! "You clowns"?? Spreading FUD?! I was quoting another poster who is normally very positive. Did it come off as FUDish? I suppose. The purpose of the post was to give perspective on the irrelevance of the departure of whats-her-face to the actually issue. Getting money. I've never commented on her leaving or conspiracy theories. Cool yet jets.

Bullboard Posts

Global Tungsten Market and Supply Security